The object of the present invention is to provide a mitochondrial dysfunction improving agent comprising a
vitamin K derivative with high delivery to mitochondria. A mitochondrial dysfunction improving agent comprising at least one of the
carboxylic acid esters or salts thereof of active
vitamin K represented by the following general formula (1) (wherein R1 and R2 are
hydrogen atoms or substituents selected from
glycine, N-
acylglycine, N-alkylglycine, N,N-dialkylglycine, N,N,N-trialkylglycine, acyl groups,
dicarboxylic acid half esters and salts thereof, at least one of R1 and R2 is
glycine, N-
acylglycine, N-alkylglycine, N,N-dialkylglycine, N,N,N-trialkylglycine, acyl groups,
dicarboxylic acid half esters and salts thereof, R3 is a group represented by the following general formula (2) or the following general formula (3), and n is an integer from 1 to 7). An agent for improving mitochondrial dysfunction, an agent for improving
amyotrophic lateral sclerosis, an agent for improving
neurodegeneration, an agent for improving Alzheimer's
disease and an agent for improving Parkinson's
disease, and an ...